Literature DB >> 15287203

The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.

Nikolaos Sotirakopoulos1, Tilemachos Tsitsios, Maria Stambolidou, George Athanasiou, Maria Peiou, Vassiliki Kokkinou, Konstantinos Mavromatidis.   

Abstract

Anemia is the main problem for patients suffering from end stage renal disease (ESRD). This study aimed to determine whether the index of rigidity (IR), that shows red blood cells (RBCs) deformability and the possible IR disturbances can provide an explanation about the cause of anemia, in patients undergoing maintenance hemodialysis (HD) or on peritoneal dialysis. The IR was determined in 39 hemodialyzed patients, who were already in dialysis for a period of time ranging from 16 to 120 months (mean+/-SD=41.8 +/-24.1) (Group A). Furthermore, the IR was measured in 32 patients on continuous ambulatory peritoneal dialysis (CAPD), who were in CAPD for a period of time ranging from 6 to 60 months (mean+/-SD = 10.7+/-9.9) (Group B). Finally, the IR was determined in 17 normal individuals (group C). The RBCs IR was measured twice in group A (before and after the end of a hemodialysis session) and once in groups B and C. The IR was determined by hemorrheometry (method of filtration), using special equipment. In group A the IR was increased in comparison to the control group (C) (17.9+/-6.2 vs. 10.2+/-1.8, p<0.0001). This increase was even higher in the measurement at the end of the hemodialysis session (paired t-test, p < 0.0001). The RBCs IR in CAPD patients was significantly lower than that of HD patients (12+/-3.8 vs. 17.9+/-6.2, p<0.0001) and was not statistically different from the control group (12+/-3.8 vs. 10.2+/-1.8, p=0.068). It is concluded from the study that: 1) in HD patients occur disturbances in the deformability of the RBCs, that are worsened by the hemodialysis session; 2) the index of rigidity of RBCs is significantly higher in the HD patients than in CAPD patients; 3) in patients on CAPD, the disturbance of deformability of the RBCs was less in comparison to the control group, which however does not reach the statistically significant levels.

Entities:  

Mesh:

Year:  2004        PMID: 15287203     DOI: 10.1081/jdi-120038517

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Microfluidic assessment of red blood cell mediated microvascular occlusion.

Authors:  Yuncheng Man; Erdem Kucukal; Ran An; Quentin D Watson; Jürgen Bosch; Peter A Zimmerman; Jane A Little; Umut A Gurkan
Journal:  Lab Chip       Date:  2020-05-19       Impact factor: 6.799

2.  Vitamin E-coated dialyzer alleviates erythrocyte deformability dysfunction in patients with end-stage renal disease undergoing hemodialysis.

Authors:  Ying Zhang; Wei Gao; Xia Li
Journal:  Exp Ther Med       Date:  2022-06-01       Impact factor: 2.751

3.  Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients.

Authors:  Miao-Pei Chen; Chien-Wen Chen; Jin-Shuen Chen; Hung-Chung Mao; Chu-Lin Chou
Journal:  Springerplus       Date:  2016-01-13

4.  Alterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysis.

Authors:  Nesrin Zeynep Ertan; Semra Bozfakioglu; Elif Ugurel; Mukaddes Sinan; Ozlem Yalcin
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

Review 5.  Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes.

Authors:  Hoyoon Lee; Wonwhi Na; Sang Bae Lee; Chul Woo Ahn; Jun Sung Moon; Kyu Chang Won; Sehyun Shin
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

6.  Early utilization of hypertonic peritoneal dialysate and subsequent risks of non-traumatic amputation among peritoneal dialysis patients: a nationwide retrospective longitudinal study.

Authors:  Shih-Yi Lin; Che-Chen Lin; Chung-Chih Lin; Chi-Jung Chung; Horng-Che Yeh; I-Kuan Wang; I-Wen Ting; Chiu-Chin Huang; Fung-Chang Sung
Journal:  BMC Nephrol       Date:  2013-06-20       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.